Bert Spilker
Impact in
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Family Practice top 5%
Papers in
-
- Pharmaceutical Economics and Policy 7
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Cardiac electrophysiology and arrhythmias 7
- Co-authors
- Enoch Callaway (3 shared papers)Joyce A. Cramer (2 shared papers)Anthony C. Segreti (1 shared paper)K. M. Dhasmana (4 shared papers)Kenneth J. Blackburn (1 shared paper)Roger A. Burges (1 shared paper)Alan L. Buchman (1 shared paper)Bita V. Naini (1 shared paper)
- Journals
- British Journal of Pharmacology (5 papers)European Journal of Pharmacology (3 papers)Cellular and Molecular Life Sciences (3 papers)Drug News & Perspectives (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Bert Spilker
52 papers receiving 2.6k citations
Bert Spilker's Hit Papers
Peers
Comparison fields: 5 of 163
- Economics and Econometrics 664
- Family Practice 48
- Psychiatry and Mental health 326
- General Health Professions 481
- Geriatrics and Gerontology 74
Countries citing papers authored by Bert Spilker
This map shows the geographic impact of Bert Spilker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Spilker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Spilker more than expected).
Fields of papers citing papers by Bert Spilker
This network shows the impact of papers produced by Bert Spilker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Spilker. The network helps show where Bert Spilker may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Spilker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quality of life and pharmacoeconomics in clinical trials Hit paper breakdown → | 1996 | 1648 |
| 2 | Guide to clinical trials | 1991 | 239 |
| 3 | 1993 | 155 | |
| 4 | Quality of life bibliography and indexes. | 1990 | 112 |
| 5 | 1992 | 61 | |
| 6 | Quality of Life and Pharmacoeconomics: An Introduction | 1998 | 49 |
| 7 | 1969 | 43 | |
| 8 | Patient recruitment in clinical trials | 1992 | 41 |
| 9 | 1969 | 34 | |
| 10 | 1969 | 31 | |
| 11 | 1984 | 30 | |
| 12 | 1969 | 29 | |
| 13 | 2017 | 27 | |
| 14 | 1996 | 22 | |
| 15 | Introduction to the field of quality of life trials | 1990 | 21 |
| 16 | 1973 | 17 | |
| 17 | 1970 | 16 | |
| 18 | 1969 | 14 | |
| 19 | 1976 | 14 | |
| 20 | 1991 | 13 |
About Bert Spilker
Bert Spilker is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health, Physiology and Molecular Biology, having authored 57 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (7 papers), Pharmaceutical Economics and Policy (7 papers), Ion channel regulation and function (5 papers), Pharmaceutical industry and healthcare (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Neural dynamics and brain function (3 papers), Health and Medical Research Impacts (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Economics and Econometrics (664 citations), Family Practice (48 citations), Psychiatry and Mental health (326 citations), General Health Professions (481 citations) and Geriatrics and Gerontology (74 citations). Bert Spilker has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Enoch Callaway, Joyce A. Cramer, Anthony C. Segreti, K. M. Dhasmana, Kenneth J. Blackburn, Roger A. Burges, Alan L. Buchman, Bita V. Naini, Peter Cervoni and Joe Kamiya. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology, Cellular and Molecular Life Sciences, Drug News & Perspectives and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.